DARE
NASDAQ · Pharmaceuticals
Dare Bioscience Inc
$2.75
-0.16 (-5.50%)
Open$2.94
Previous Close$2.91
Day High$2.94
Day Low$2.65
52W High$9.19
52W Low$1.27
Volume—
Avg Volume1.04M
Market Cap40.04M
P/E Ratio—
EPS$-0.88
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+49.8% upside
Current
$2.75
$2.75
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.34M | 2.86M | 6.37M |
| Net Income | -17,451,018 | -33,502,380 | 1.14M |
| Profit Margin | -1,300.7% | -1,235.6% | 17.9% |
| EBITDA | -15,136,058 | -30,672,472 | 1.58M |
| Free Cash Flow | — | — | 772.3K |
| Rev Growth | -53.1% | -53.1% | +7.5% |
| Debt/Equity | 2.42 | 2.42 | 0.72 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |